
We have an update on a post we published late last month.
We reported on March 31 that Tissue Engineering had retracted a paper by Xing Wei, of the, National Engineering Research Center of Genetic Medicine at Jinan University, in Guangzhou, China, because of image manipulation. The retraction notice for that paper, “Use of Decellularized Scaffolds Combined with Hyaluronic Acid and Basic Fibroblast Growth Factor for Skin Tissue Engineering, referred to another paper in the journal that was being retracted, but had not yet been. It also referred to a paper in a different journal that showed signs of misconduct, but that had yet to be retracted, either.
We were checking this week to see if the other papers had been retracted, mostly just to make sure our database was up to date. The second paper, Promoting the Recovery of Injured Liver with Poly (3-Hydroxybutyrate-Co-3-Hydroxyvalerate-Co-3-Hydroxyhexanoate) Scaffolds Loaded with Umbilical Cord-Derived Mesenchymal Stem Cells, has indeed been retracted, although the one in Tissue Engineering Constructs and Cell Substrates has not.
What was far more interesting, however, was that when we looked at a retraction notice for the first paper, we saw something we hadn’t seen in it before: Wei had earned an “indefinite ban” from publishing in the journal:
Continue reading The tale of the secret publishing ban